Higher incidence of arrhythmia in COVID-19 than in other community-acquired pneumonia: possible role of concurrent therapies
Main Authors: | Patrick M. Honore, Sebastien Redant, Thierry Preseau, Sofie Moorthamers, Keitiane Kaefer, Leonel Barreto Gutierrez, Rachid Attou, Andrea Gallerani, David De Bels |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | Critical Care |
Online Access: | https://doi.org/10.1186/s13054-021-03655-w |
Similar Items
-
Success rate of naso-jejunal tube placement influenced by CRRT: possible removal of metoclopramide
by: Patrick M. Honore, et al.
Published: (2021-06-01) -
Comparison between meropenem and ceftolozane/tazobactam: possible influence of CRRT
by: Patrick M. Honore, et al.
Published: (2022-01-01) -
Indirect calorimetry is the gold standard to assess REE in ICU patients: some limitations to consider
by: Patrick M. Honore, et al.
Published: (2021-11-01) -
Study find that COVID ARDS was associated with a low risk for possible or proven PCP: still true after dexamethasone use
by: Patrick M. Honore, et al.
Published: (2022-02-01) -
Biomarker suPAR seems a good prognostic factor for community-acquired pneumonia but less prominent for septic shock
by: Patrick M. Honore, et al.
Published: (2019-12-01)